magnesium sulfate has been researched along with Infant, Premature, Diseases in 102 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (5.88) | 18.7374 |
1990's | 10 (9.80) | 18.2507 |
2000's | 23 (22.55) | 29.6817 |
2010's | 50 (49.02) | 24.3611 |
2020's | 13 (12.75) | 2.80 |
Authors | Studies |
---|---|
David, AL; Mendonça, M; Morgan, AS; Thiele, N | 1 |
Carlsson, Y; Hagberg, H; Jonsdotter, A; Rocha-Ferreira, E | 1 |
Chahin, N; Forsthoffer, B; Hendricks-Muñoz, KD; Richards, A; Xu, J; Yitayew, MS | 1 |
Brion, LP; Chawla, S; DeMauro, SB; Foglia, EE; Ramachandran, S; Wyckoff, MH | 1 |
Aronoff, N; Chandrasekharan, P; Diggikar, S; Prasath, A | 1 |
Canpolat, FE; Elbayiyev, S; Kanmaz Kutman, HG; Oguz, SS; Oguz, Y; Ozer Bekmez, B; Tayman, C; Uygur, D | 1 |
Akaba, K; Aoki, K | 1 |
Ahn, SY; Chang, YS; Choi, SJ; Choi, YS; Hong, JY; Kim, HS; Kim, YM; Oh, SY; Park, WS; Roh, CR; Sung, JH; Sung, SI | 1 |
Brackney, K; Gibson, KS | 1 |
Cho, H; Hong, S; Kim, EK; Kim, HS; Kim, SH; Kim, YJ; Lee, SM; Shin, SH | 1 |
Chandran, S; Joshi, A; Kumar, M; Rebekah, G; Ross, B; Tergestina, M | 1 |
Callander, EJ; Crowther, C; Groves, C; Keir, AK; McIntyre, S; Rumbold, A; Shepherd, E | 1 |
Barrett, JFR; Chari, RS; Dunn, MS; Jones, G; Ladhani, NNN; Shah, P | 1 |
Garg, BD | 1 |
Lingam, I; Robertson, NJ | 1 |
Dietz, RM; Paulsen, ME | 1 |
Caritis, SN; Clark, EAS; Dudley, DJ; Hankins, GDV; Iams, JD; Malone, FD; Mercer, BM; O'Sullivan, MJ; Peaceman, AM; Reddy, UM; Rouse, DJ; Sorokin, Y; Wapner, RJ; Weiner, SJ | 1 |
Ancel, PY; Benhammou, V; d'Ercole, C; Delorme, P; Foix-L'Hélias, L; Gire, C; Goffinet, F; Kayem, G; Lorthe, E; Marchand-Martin, L; Sentilhes, L; Subtil, D; Torchin, H; Winer, N | 1 |
Haak, P; Korzeniewski, SJ; Lenski, M; Paneth, N; Slaughter, J | 1 |
Brookfield, KF; Vinson, A | 1 |
Bhakta, KY; Bronson, C; Curran, M; Mikhael, M; Rodriguez, H; Zhang, L | 1 |
Alvaro, R; Claveau, M; Garfinkle, J; Lee, SK; Nwaesei, C; Shah, PS; Yoon, EW | 1 |
Ashwood, P; Crowther, CA; Haslam, R; Middleton, PF; Wilkinson, D | 1 |
Andonotopo, W; Bachnas, MA; Effendi, JS; Mose, JC | 1 |
Gibbins, KJ; Rouse, DJ | 1 |
Ashwood, P; Bain, E; Bubner, T; Crowther, CA; Flenady, V; McIntyre, S; Middleton, PF; Morris, J | 1 |
Berggren, EK; Leung, EY | 1 |
Bénichou, J; Chollat, C; Enser, M; Houivet, E; Marpeau, L; Marret, S; Provost, D | 1 |
Cotten, CM; Drinker, LR; Goldberg, RN; Kraus, DM; Rattray, BN; Tanaka, DT | 1 |
Ball, MB; Bara, R; Bell, EF; Carlo, WA; Das, A; De Jesus, LC; Hale, EC; Higgins, RD; Kendrick, D; Laptook, AR; Newman, NS; Sanchez, PJ; Shankaran, S; Sood, BG; Stoll, BJ; Van Meurs, KP; Walsh, MC | 1 |
Caritis, SN; Hankins, GD; Horton, AL; Iams, JD; Lai, Y; Leveno, KJ; Malone, FD; Mercer, BM; O'Sullivan, MJ; Ramin, SM; Rouse, DJ; Sorokin, Y; Spong, CY; Thorp, JM; Varner, MW; Wapner, RJ | 1 |
Andersen, CC; Hodyl, NA; Stark, MJ | 1 |
Drassinower, D; Friedman, AM; Gyamfi-Bannerman, C; Levin, H; Običan, SG | 1 |
Clark, E; Kamyar, M; Manuck, TA; Stoddard, GJ; Varner, MW | 1 |
Izbizky, G; Meller, CH; Otaño, L | 1 |
Huang, CC; Tu, YF; Wang, LW; Wang, ST; Yeh, TF | 1 |
Hirtz, D; Rouse, DJ | 1 |
Dotters-Katz, SK; Manuck, TA; Metz, TD; Smid, MC | 1 |
Clark, RH; Cotten, CM; Downey, LC; Hornik, CP; Laughon, MM; Smith, PB; Tolia, VN | 1 |
Ancel, PY; Marret, S | 1 |
Bhagat, I; Dechert, R; Donn, SM; Sarkar, S; Schumacher, RE | 1 |
Elliott, JP; Garite, TJ; Lewis, DF; Morrison, JC | 1 |
Crowther, CA; Doyle, LW; Marret, S; Middleton, P | 2 |
Macones, GA | 1 |
Cahill, AG; Caughey, AB | 1 |
Rouse, DJ | 2 |
Conde-Agudelo, A; Romero, R | 1 |
Bastek, JA; Elovitz, MA; Sammel, MD; Srinivas, SK | 1 |
Beucher, G; Dreyfus, M | 1 |
Marret, S | 1 |
Enomoto, M; Hayashi, S; Katayama, Y; Lee, YK; Minami, H; Takano, T | 1 |
Brok, J; Gluud, C; Huusom, LD; Pryds, O; Secher, NJ; Whitfield, K | 1 |
Caughey, AB; El-Sayed, YY; Greenberg, MB; Lyell, DJ; Penn, AA; Thomas, LJ | 1 |
Imberger, G; Wetterslev, J | 1 |
Crowther, C; Doyle, L; Marret, S; Middleton, P; Rouse, D; Voysey, M | 1 |
Mehta, R; Petrova, A | 1 |
Basu, SK; Bhutada, A; Chickajajur, V; Lopez, V; Pagala, M; Rastogi, S | 1 |
Brennecke, S; Costa, Fda S; Lopes, L | 1 |
Sibai, BM | 1 |
Doyle, LW | 1 |
Combs, CA; Garite, TJ | 1 |
Kennedy, A; McCarthy, EA; Ow, LL; Walker, SP | 1 |
Haddad, B; Kayem, G; Mandelbrot, L | 1 |
Ashwood, P; Bain, E; Bubner, T; Crowther, CA; Middleton, P | 1 |
Dean, C; Douglas, J | 1 |
Repke, JT | 1 |
Anderson, BL; Browning, KR; Gibbins, KJ; Lopes, VV; Rouse, DJ | 1 |
Elimian, A; Ogburn, P; Quirk, JG; Spitzer, A; Verma, R; Wiencek, V | 1 |
Crowther, CA; Doyle, LW; Haslam, RR; Hiller, JE | 1 |
Gilstrap, LC; Tyson, JE | 1 |
Lee, KS; Mittendorf, R; Pryde, PG; Roizen, NJ | 1 |
Ananth, CV; Vintzileos, AM | 1 |
Mittendorf, R; Pryde, PG; Roizen, NJ | 1 |
Abbasi, S; Fisher, L; Gerdes, JS; Ludmir, J; Marchiano, DA; Robertson, P; Sehdev, HM | 1 |
Abubakar, K; Deering, SH; Ghidini, A; Pezzullo, JC; Spong, CY; Stagg, AR | 1 |
Blair, E; Watson, L | 1 |
Garrison, RD; Hudak, ML; Sharma, R; Teng, RJ; Wu, TJ | 1 |
McAdams, RM | 1 |
Bancalari, E; Claure, N; del moral, T; Gonzalez-Quintero, VH; Vanbuskirk, S | 1 |
Astruc, D; Bénichou, J; Bruel, H; Cambonie, G; Delaporte, B; Follet-Bouhamed, C; Guillois, B; Marpeau, L; Marret, S; Pinquier, D; Zupan-Simunek, V | 1 |
Brady, JP; Williams, HC | 1 |
Barke, JI; de Veciana, M; Major, CA; Porto, M | 1 |
Teng, RJ; Tsou, KI; Wu, TJ | 1 |
Doğan, M; Ekici, E; Gökmen, O; Kaleli, B; Karayalçin, R; Ozcan, T; Turan, C; Uludağ, H | 1 |
Blair, E; Palmer, L; Stanley, F | 1 |
Gee, JB; Perlman, JM; Risser, RC | 1 |
Volpe, JJ | 1 |
Hirtz, DG; Nelson, K | 1 |
Ascarelli, MH; Calfee, EL; Morrison, JC; Perry, KG; Ross, EL; Rust, OA; Schorr, SJ | 1 |
Canterino, JC; Figueroa, R; Klein, SA; Tejani, NA; Verma, UL; Visintainer, PF | 1 |
Espada, RA; Ghidini, A; Spong, CY | 1 |
Narchi, H | 1 |
Fenton, T; Kuban, KC; Leviton, A; Pagano, M; Strassfeld, R; Wolff, M | 1 |
Creasy, RK; Gonik, B | 1 |
Caddell, JL | 1 |
Abramson, S; Amodio, J; Berdon, W; Stolar, C | 1 |
Hayashi, RH; Marshall, CL | 1 |
Lipsitz, PJ | 1 |
19 review(s) available for magnesium sulfate and Infant, Premature, Diseases
Article | Year |
---|---|
Antenatal Magnesium Sulfate and adverse gastrointestinal outcomes in Preterm infants-a systematic review and meta-analysis.
Topics: Enterocolitis, Necrotizing; Humans; Incidence; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate | 2023 |
Periviable Premature Rupture of Membranes.
Topics: Adrenal Cortex Hormones; Amniotic Fluid; Anti-Bacterial Agents; Bronchopulmonary Dysplasia; Cerclage, Cervical; Chorioamnionitis; Female; Fetal Membranes, Premature Rupture; Fetal Viability; Gestational Age; Humans; Infant, Extremely Premature; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate; Pregnancy; Pregnancy Outcome; Premature Birth | 2020 |
Antenatal magnesium sulfate is beneficial or harmful in very preterm and extremely preterm neonates: a new insight.
Topics: Anticonvulsants; Female; Gastrointestinal Diseases; Humans; Infant, Extremely Premature; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate; Pregnancy | 2019 |
Magnesium as a Neuroprotective Agent: A Review of Its Use in the Fetus, Term Infant with Neonatal Encephalopathy, and the Adult Stroke Patient.
Topics: Adult; Animals; Brain; Brain Diseases; Fetus; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Neuroprotective Agents; Stroke | 2018 |
The complex aetiology of cerebral palsy.
Topics: Anticonvulsants; Cerebral Palsy; Child; Congenital Abnormalities; Female; Genetic Predisposition to Disease; Humans; Hypothermia, Induced; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate; Pregnancy; Pregnancy Complications | 2018 |
Magnesium sulfate use for fetal neuroprotection.
Topics: Central Nervous System Diseases; Dose-Response Relationship, Drug; Female; Humans; Infant, Premature, Diseases; Magnesium Sulfate; Maternal-Fetal Exchange; Neuroprotective Agents; Pregnancy; Premature Birth; Prenatal Care; Retrospective Studies; Risk Assessment | 2019 |
What we learned about the role of antenatal magnesium sulfate for the prevention of cerebral palsy.
Topics: Adult; Case-Control Studies; Cerebral Palsy; Double-Blind Method; Evidence-Based Medicine; Female; Humans; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate; Neuroprotective Agents; Pilot Projects; Pregnancy; Premature Birth; Prenatal Care; Randomized Controlled Trials as Topic; Treatment Outcome | 2016 |
[Neuroprotection for preterm infants with antenatal magnesium sulphate].
Topics: Adult; Cerebral Palsy; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Neuroprotective Agents; Pregnancy; Premature Birth | 2016 |
In defense of magnesium sulfate.
Topics: Cerebral Palsy; Female; Humans; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate; Obstetric Labor, Premature; Pregnancy; Tocolytic Agents | 2009 |
Antenatal magnesium sulfate and neurologic outcome in preterm infants: a systematic review.
Topics: Cerebral Palsy; Female; Humans; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate; Obstetric Labor, Premature; Pregnancy | 2009 |
Magnesium for neuroprophylaxis: fact or fiction?
Topics: Cerebral Palsy; Humans; Infant, Newborn; Infant, Premature, Diseases; Magnesium; Magnesium Sulfate; Prospective Studies; Randomized Controlled Trials as Topic | 2009 |
Antenatal magnesium sulfate for the prevention of cerebral palsy in preterm infants less than 34 weeks' gestation: a systematic review and metaanalysis.
Topics: Cerebral Palsy; Gestational Age; Humans; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate; Randomized Controlled Trials as Topic | 2009 |
Antenatal magnesium sulfate and neuroprotection.
Topics: Cerebral Palsy; Evidence-Based Medicine; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Meta-Analysis as Topic; Neuroprotective Agents; Pregnancy; Prenatal Care; Randomized Controlled Trials as Topic | 2012 |
Antenatal magnesium individual participant data international collaboration: assessing the benefits for babies using the best level of evidence (AMICABLE).
Topics: Cerebral Palsy; Evidence-Based Medicine; Female; Fetal Death; Humans; Infant Mortality; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate; Neuroprotective Agents; Pregnancy; Pregnancy Outcome; Premature Birth; Prenatal Care; Randomized Controlled Trials as Topic; Risk Factors | 2012 |
[Use of magnesium sulfate in obstetrics].
Topics: Cerebral Palsy; Eclampsia; Female; Humans; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate; Neuroprotective Agents; Obstetric Labor, Premature; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Randomized Controlled Trials as Topic | 2012 |
Magnesium and the obstetric anaesthetist.
Topics: Adjuvants, Anesthesia; Analgesics; Anesthesia, Obstetrical; Anesthesiology; Cerebral Palsy; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium; Magnesium Sulfate; Neuroprotective Agents; Obstetric Labor, Premature; Pre-Eclampsia; Pregnancy; Premature Birth | 2013 |
Epidemiology of cerebral palsy.
Topics: Adrenal Cortex Hormones; Cerebral Palsy; Female; Gestational Age; Humans; Hypocapnia; Hypothermia, Induced; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Inflammation; Magnesium Sulfate; Pre-Eclampsia; Pregnancy; Pregnancy, Multiple; Severity of Illness Index; Tocolytic Agents | 2006 |
Brain injury in the premature infant. Neuropathology, clinical aspects, pathogenesis, and prevention.
Topics: Brain Diseases; Cell Death; Cerebral Hemorrhage; Cerebral Infarction; Cerebrovascular Circulation; Free Radical Scavengers; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Leukomalacia, Periventricular; Magnesium Sulfate; Oligodendroglia; Spectroscopy, Near-Infrared; Tocolytic Agents | 1997 |
Magnesium sulfate and cerebral palsy in premature infants.
Topics: Animals; Cerebral Palsy; Cerebrovascular Circulation; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Tocolytic Agents | 1998 |
14 trial(s) available for magnesium sulfate and Infant, Premature, Diseases
Article | Year |
---|---|
Genetic Variation, Magnesium Sulfate Exposure, and Adverse Neurodevelopmental Outcomes Following Preterm Birth.
Topics: Case-Control Studies; Cerebral Palsy; Child, Preschool; Female; Genetic Variation; Gestational Age; Humans; Infant; Infant Mortality; Infant, Newborn; Infant, Premature, Diseases; Logistic Models; Magnesium Sulfate; Male; Neurodevelopmental Disorders; Neuroprotective Agents; Polymorphism, Single Nucleotide; Pregnancy; Premature Birth; Prenatal Care; Prenatal Exposure Delayed Effects; Psychomotor Disorders; Receptors, Interleukin-6; Stillbirth | 2018 |
Magnesium sulphate at 30 to 34 weeks' gestational age: neuroprotection trial (MAGENTA)--study protocol.
Topics: Blindness; Calcium Channel Blockers; Cerebral Palsy; Child Behavior; Child, Preschool; Deafness; Developmental Disabilities; Female; Gestational Age; Health Status; Humans; Infant; Infant Mortality; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Perinatal Mortality; Pregnancy; Premature Birth; Psychological Tests; Research Design; Stillbirth | 2013 |
Influence of antenatal magnesium sulfate application on cord blood levels of brain-derived neurotrophic factor in premature infants.
Topics: Administration, Intravenous; Adult; Biomarkers; Brain-Derived Neurotrophic Factor; Cerebral Palsy; Drug Administration Schedule; Enzyme-Linked Immunosorbent Assay; Female; Fetal Blood; Follow-Up Studies; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Neuroprotective Agents; Pre-Eclampsia; Pregnancy; Premature Birth; Prenatal Care | 2014 |
School-age outcomes following a randomized controlled trial of magnesium sulfate for neuroprotection of preterm infants.
Topics: Adolescent; Cerebral Palsy; Child; Female; Follow-Up Studies; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Male; Neuroprotective Agents; Pregnancy; Prenatal Exposure Delayed Effects; Psychomotor Performance; Surveys and Questionnaires; Treatment Outcome | 2014 |
Effect of magnesium sulfate administration for neuroprotection on latency in women with preterm premature rupture of membranes.
Topics: Adult; Cerebral Palsy; Delivery, Obstetric; Female; Fetal Membranes, Premature Rupture; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Neuroprotective Agents; Obstetric Labor, Premature; Pregnancy; Tocolytic Agents; Treatment Outcome; Young Adult | 2015 |
Does magnesium exposure affect neonatal resuscitation?
Topics: Apgar Score; Cerebral Palsy; Female; Humans; Hypotension; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Linear Models; Magnesium Sulfate; Muscle Hypotonia; Neuroprotective Agents; Pregnancy; Premature Birth; Prenatal Exposure Delayed Effects; Resuscitation | 2015 |
Magnesium sulfate, chorioamnionitis, and neurodevelopment after preterm birth.
Topics: Adult; Cerebral Palsy; Chorioamnionitis; Female; Humans; Infant; Infant Mortality; Infant, Premature, Diseases; Magnesium Sulfate; Male; Neurodevelopmental Disorders; Neuroprotective Agents; Pregnancy; Premature Birth; Prenatal Care; Prenatal Exposure Delayed Effects; Psychomotor Disorders; Stillbirth | 2016 |
Risk of neonatal and childhood morbidity among preterm infants exposed to marijuana.
Topics: Cannabis; Cerebral Palsy; Child Development; Child, Preschool; Developmental Disabilities; Female; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Male; Marijuana Abuse; Morbidity; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Risk Factors | 2017 |
Evaluation of the clinical use of magnesium sulfate for cerebral palsy prevention.
Topics: Adult; Cerebral Palsy; Clinical Protocols; Female; Humans; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate; Pregnancy; Prenatal Care | 2013 |
Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial.
Topics: Cerebral Palsy; Developmental Disabilities; Female; Humans; Infant; Infant Mortality; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Neuroprotective Agents; Obstetric Labor, Premature; Pregnancy; Pregnancy Outcome; Pregnancy, High-Risk | 2003 |
[Effect of magnesium sulphate on mortality and neurologic morbidity of the very-preterm newborn (of less than 33 weeks) with two-year neurological outcome: results of the prospective PREMAG trial].
Topics: Adult; Cerebral Palsy; Female; Humans; Infant Mortality; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Leukomalacia, Periventricular; Longitudinal Studies; Magnesium Sulfate; Male; Morbidity; Nervous System Diseases; Obstetric Labor, Premature; Pregnancy; Pregnancy Outcome; Prospective Studies; Tocolytic Agents; Treatment Outcome | 2008 |
Tocolysis in advanced preterm labor: impact on neonatal outcome.
Topics: Cohort Studies; Female; Humans; Indomethacin; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate; Obstetric Labor, Premature; Pregnancy; Pregnancy Outcome; Respiratory Distress Syndrome, Newborn; Tocolysis | 1995 |
Persistent pulmonary hypertension of the newborn treated with magnesium sulfate in premature neonates.
Topics: Female; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infusions, Intravenous; Linear Models; Magnesium Sulfate; Male; Persistent Fetal Circulation Syndrome; Prospective Studies; Treatment Outcome | 1995 |
A comparative study of ketorolac (Toradol) and magnesium sulfate for arrest of preterm labor.
Topics: Adult; Birth Weight; Female; Gestational Age; Humans; Infant, Newborn; Infant, Premature, Diseases; Infusions, Intravenous; Injections, Intramuscular; Ketorolac Tromethamine; Magnesium Sulfate; Obstetric Labor, Premature; Pregnancy; Prospective Studies; Tocolysis; Tocolytic Agents; Tolmetin; Treatment Outcome | 1998 |
69 other study(ies) available for magnesium sulfate and Infant, Premature, Diseases
Article | Year |
---|---|
Management and outcomes of extreme preterm birth.
Topics: Adult; Decision Making, Shared; Female; Humans; Infant, Extremely Premature; Infant, Newborn; Infant, Premature, Diseases; Intensive Care, Neonatal; Magnesium Sulfate; Male; Neurodevelopmental Disorders; Perinatal Care; Peripartum Period; Pregnancy; Premature Birth | 2022 |
Maternal and fetal serum concentrations of magnesium after administration of a 6-g bolus dose of magnesium sulfate (MgSO
Topics: Cerebral Palsy; Female; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases; Magnesium; Magnesium Sulfate; Neuroprotective Agents; Pregnancy; Premature Birth; Prenatal Care | 2022 |
Ascorbic Acid and the Premature Infant.
Topics: Ascorbic Acid; Female; Gestational Age; Humans; Infant; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Pregnancy; Prospective Studies | 2022 |
Perinatal management: Lessons learned from the neonatal research network.
Topics: Child; Female; Humans; Infant; Infant, Extremely Premature; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate; National Institute of Child Health and Human Development (U.S.); Parturition; Pregnancy; United States | 2022 |
Antenatal Neuroprotective Magnesium Sulfate in Very Preterm Infants and Its Association With Feeding Intolerance.
Topics: Female; Fetal Growth Retardation; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Neuroprotection; Pregnancy | 2023 |
Characteristics of nonoliguric hyperkalemia in preterm infants: A case-control study in a single center.
Topics: Adult; Case-Control Studies; Female; Gestational Age; Humans; Hyperkalemia; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Male; Mothers; Multivariate Analysis; Odds Ratio; Oliguria; Potassium; Pregnancy; Risk Factors | 2020 |
Antenatal magnesium sulfate treatment and risk of necrotizing enterocolitis in preterm infants born at less than 32 weeks of gestation.
Topics: Cohort Studies; Eclampsia; Enterocolitis, Necrotizing; Female; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Maternal-Fetal Exchange; Negative Results; Pregnancy; Premature Birth; Prenatal Care; Prenatal Exposure Delayed Effects; Retrospective Studies; Risk | 2020 |
Antenatal magnesium sulfate and intestinal morbidities in preterm infants with extremely low gestational age.
Topics: Cohort Studies; Drug Administration Schedule; Enterocolitis, Necrotizing; Female; Humans; Infant; Infant, Extremely Premature; Infant, Newborn; Infant, Premature, Diseases; Intestinal Perforation; Magnesium Sulfate; Male; Pregnancy; Prenatal Care; Retrospective Studies; Tocolytic Agents | 2021 |
Effects of Antenatal Magnesium Sulfate on the Gut Function of Preterm (<32 weeks) Very Low Birth Weight Neonates: Experience from a Tertiary Institute in South India.
Topics: Enterocolitis, Necrotizing; Female; Humans; India; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Magnesium Sulfate; Pregnancy; Prospective Studies | 2021 |
Antenatal magnesium sulfate to prevent cerebral palsy.
Topics: Calcium Channel Blockers; Cerebral Palsy; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Pregnancy; Premature Birth | 2022 |
No. 347-Obstetric Management at Borderline Viability.
Topics: Adrenal Cortex Hormones; Delivery, Obstetric; Female; Fetal Viability; Gestational Age; Humans; Infant, Premature, Diseases; Magnesium Sulfate; Patient Transfer; Pregnancy; Premature Birth | 2017 |
Magnesium sulfate prevents cerebral palsy in premature infants.
Topics: Cerebral Palsy; Female; Humans; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Pregnancy | 2018 |
Preterm premature rupture of membranes at 22-25 weeks' gestation: perinatal and 2-year outcomes within a national population-based study (EPIPAGE-2).
Topics: Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Bronchopulmonary Dysplasia; Cerebral Intraventricular Hemorrhage; Cerebral Palsy; Cesarean Section; Child, Preschool; Enterocolitis, Necrotizing; Female; Fetal Membranes, Premature Rupture; Fetal Mortality; Fetal Viability; France; Gestational Age; Humans; Infant; Infant, Extremely Premature; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Labor, Obstetric; Leukomalacia, Periventricular; Magnesium Sulfate; Patient Transfer; Perinatal Mortality; Pregnancy; Pregnancy Trimester, Second; Prenatal Care; Retinopathy of Prematurity; Stillbirth; Survival Rate; Tocolysis; Tocolytic Agents | 2018 |
Lack of Evidence for Time or Dose Relationship between Antenatal Magnesium Sulfate and Intestinal Injury in Extremely Preterm Neonates.
Topics: California; Dose-Response Relationship, Drug; Female; Gestational Age; Humans; Infant, Extremely Premature; Infant, Newborn; Infant, Premature, Diseases; Infant, Small for Gestational Age; Intestinal Perforation; Logistic Models; Magnesium Sulfate; Male; Multivariate Analysis; Pregnancy; Prenatal Exposure Delayed Effects; Retrospective Studies | 2019 |
Trends in sex-specific differences in outcomes in extreme preterms: progress or natural barriers?
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Apgar Score; Birth Weight; Canada; Comorbidity; Female; Health Status; Humans; Infant, Extremely Premature; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate; Male; Pulmonary Surfactants; Respiration, Artificial; Retrospective Studies; Sex Factors | 2020 |
Magnesium sulfate for cerebral palsy prevention.
Topics: Cerebral Palsy; Drug Administration Schedule; Female; Gestational Age; Humans; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate; Practice Guidelines as Topic; Pregnancy; Pregnancy, High-Risk; Prenatal Care; Randomized Controlled Trials as Topic; Tocolytic Agents | 2013 |
Working to improve survival and health for babies born very preterm: the WISH project protocol.
Topics: Australia; Cerebral Palsy; Child, Preschool; Evidence-Based Medicine; Female; Gestational Age; Guideline Adherence; Hospitals, Maternity; Humans; Infant; Infant, Extremely Premature; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate; Medical Audit; Neuroprotective Agents; New Zealand; Practice Guidelines as Topic; Pregnancy; Premature Birth; Prenatal Care; Prospective Studies; Research Design | 2013 |
A report from #BlueJC: are we convinced antenatal magnesium sulphate can prevent cerebral palsy in preterm infants?
Topics: Central Nervous System Agents; Cerebral Palsy; Female; Humans; Infant, Premature, Diseases; Magnesium Sulfate; Pregnancy; Prenatal Care | 2014 |
Antenatal magnesium sulfate and spontaneous intestinal perforation in infants less than 25 weeks gestation.
Topics: Adult; Female; Gestational Age; Humans; Infant, Extremely Low Birth Weight; Infant, Newborn; Infant, Premature, Diseases; Intestinal Perforation; Magnesium Sulfate; Multivariate Analysis; Neuroprotective Agents; Tocolytic Agents | 2014 |
Antenatal magnesium sulfate exposure and acute cardiorespiratory events in preterm infants.
Topics: Acute Disease; Adult; Female; Heart Diseases; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Pregnancy; Prenatal Exposure Delayed Effects; Respiration Disorders; Retrospective Studies; Young Adult | 2015 |
Effects of antenatal magnesium sulfate treatment for neonatal neuro-protection on cerebral oxygen kinetics.
Topics: Brain; Brain Injuries; Carotid Arteries; Cerebrovascular Circulation; Female; Gestational Age; Hemodynamics; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Kinetics; Magnesium Sulfate; Male; Maternal Exposure; Neuroprotective Agents; Oxygen; Oxygen Consumption; Pregnancy; Prenatal Care; Spectroscopy, Near-Infrared; Tocolytic Agents | 2015 |
Update on the use of magnesium sulphate for fetal neuroprotection in preterm birth.
Topics: Brain Diseases; Fetal Diseases; Humans; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate; Practice Guidelines as Topic; Premature Birth | 2015 |
Postnatal Steroids and Febrile Seizure Susceptibility in Preterm Children.
Topics: Adrenal Cortex Hormones; Child, Preschool; Disease Susceptibility; Epilepsy; Female; Gestational Age; Humans; Incidence; Indomethacin; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Magnesium Sulfate; Male; Prospective Studies; Risk Factors; Seizures, Febrile | 2016 |
Association of in utero magnesium exposure and spontaneous intestinal perforations in extremely low birth weight infants.
Topics: Databases, Factual; Female; Humans; Infant; Infant Mortality; Infant, Extremely Low Birth Weight; Infant, Newborn; Infant, Premature, Diseases; Intensive Care Units, Neonatal; Intestinal Perforation; Logistic Models; Magnesium Sulfate; Male; Maternal Exposure; Multivariate Analysis; North America; Retrospective Studies | 2017 |
Severe intraventricular hemorrhage in preterm infants: comparison of risk factors and short-term neonatal morbidities between grade 3 and grade 4 intraventricular hemorrhage.
Topics: Apgar Score; Birth Weight; Cause of Death; Cerebral Hemorrhage; Female; Gestational Age; Humans; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate; Male; Michigan; Multivariate Analysis; Pregnancy; Retrospective Studies; Risk Factors; Steroids; Survival Rate; Time Factors | 2009 |
MgSO4 for CP prevention: too good to be true?
Topics: Cerebral Palsy; Humans; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate | 2009 |
Magnesium sulfate for the prevention of cerebral palsy.
Topics: Cerebral Palsy; Humans; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate; Neuroprotective Agents; Randomized Controlled Trials as Topic | 2009 |
Do neonatal outcomes differ depending on the cause of preterm birth? A comparison between spontaneous birth and iatrogenic delivery for preeclampsia.
Topics: Adult; Anti-Bacterial Agents; Betamethasone; Case-Control Studies; Delivery, Obstetric; Drug Utilization; Female; Fetal Growth Retardation; Gestational Age; Glucocorticoids; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Intensive Care Units, Neonatal; Length of Stay; Magnesium Sulfate; Male; Pre-Eclampsia; Pregnancy; Premature Birth; Prospective Studies; Respiration, Artificial; Retrospective Studies; Tocolytic Agents | 2010 |
[Efficiency of magnesium sulfate for the prevention of eclampsia in women with preeclampsia].
Topics: Calcium Channel Blockers; Central Nervous System Diseases; Eclampsia; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Neuroprotective Agents; Obstetric Labor, Premature; Pre-Eclampsia; Pregnancy; Treatment Outcome | 2010 |
[Magnesium sulphate: an improvement in the field of preterm infant neuroprotection].
Topics: Central Nervous System Diseases; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Neuroprotective Agents; Premature Birth | 2010 |
Antenatal magnesium sulfate and the postnatal response of the ductus arteriosus to indomethacin in extremely preterm neonates.
Topics: Drug Administration Schedule; Ductus Arteriosus; Ductus Arteriosus, Patent; Female; Gestational Age; Humans; Incidence; Indomethacin; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Logistic Models; Magnesium Sulfate; Male; Pregnancy; Prenatal Care; Retrospective Studies; Tocolytic Agents; Treatment Outcome | 2011 |
Antenatal magnesium sulphate may prevent cerebral palsy in preterm infants--but are we convinced? Evaluation of an apparently conclusive meta-analysis with trial sequential analysis.
Topics: Central Nervous System Agents; Cerebral Palsy; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Meta-Analysis as Topic; Pregnancy; Prenatal Care | 2011 |
Neonatal medical admission in a term and late-preterm cohort exposed to magnesium sulfate.
Topics: Adult; Cohort Studies; Female; Humans; Infant, Newborn; Infant, Premature, Diseases; Intensive Care Units, Neonatal; Magnesium Sulfate; Male; Maternal-Fetal Exchange; Patient Admission; Pregnancy; Retrospective Studies; Term Birth | 2011 |
The information gap between the required and the actual accrued information size in the meta-analysis of antenatal magnesium sulphate to prevent cerebral palsy in preterm infants.
Topics: Central Nervous System Agents; Cerebral Palsy; Female; Humans; Infant, Premature, Diseases; Magnesium Sulfate; Pregnancy; Prenatal Care | 2011 |
Antenatal magnesium sulphate to prevent cerebral palsy in very preterm infants.
Topics: Central Nervous System Agents; Cerebral Palsy; Female; Humans; Infant, Premature, Diseases; Magnesium Sulfate; Pregnancy; Prenatal Care | 2011 |
Magnesium sulfate tocolysis and intraventricular hemorrhage in very preterm infants.
Topics: Case-Control Studies; Cerebral Hemorrhage; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Intensive Care Units, Neonatal; Magnesium Sulfate; Male; Obstetric Labor, Premature; Pregnancy; Tocolysis; Tocolytic Agents | 2012 |
Immediate clinical outcomes in preterm neonates receiving antenatal magnesium for neuroprotection.
Topics: Cerebral Palsy; Ductus Arteriosus, Patent; Female; Gestational Age; Humans; Infant Mortality; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium; Magnesium Sulfate; Neuroprotective Agents; Pregnancy; Retinopathy of Prematurity; Retrospective Studies; Treatment Outcome | 2011 |
Magnesium sulphate for fetal neuroprotection.
Topics: Cerebral Palsy; Female; Humans; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate; Neuroprotective Agents; Pregnancy; Prenatal Care | 2011 |
Magnesium sulfate for fetal neuroprotection.
Topics: Cerebral Palsy; Fetal Diseases; Humans; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate; Neuroprotective Agents | 2011 |
Magnesium sulfate for neuroprotection in patients at risk for early preterm delivery: not yet.
Topics: Cerebral Palsy; Female; Humans; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate; Neuroprotective Agents; Pregnancy; Premature Birth; Risk Factors | 2011 |
Obstetric interventions beneficial to prematurely delivering newborn babies: antenatal corticostetroids, progesterone, magnesium sulfate.
Topics: Adrenal Cortex Hormones; Cerebral Palsy; Female; Fetal Death; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Neuroprotective Agents; Pregnancy; Premature Birth; Prenatal Care; Progesterone | 2012 |
Feasibility of implementing magnesium sulphate for neuroprotection in a tertiary obstetric unit.
Topics: Australia; Cerebral Palsy; Cohort Studies; Feasibility Studies; Female; Humans; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate; Neuroprotective Agents; Obstetric Labor, Premature; Pregnancy; Pregnancy Complications; Premature Birth; Retrospective Studies; Tertiary Care Centers; Translational Research, Biomedical | 2012 |
Patient safety checklist No. 7: magnesium sulfate before anticipated preterm birth for neuroprotection.
Topics: Checklist; Female; Humans; Infant, Premature, Diseases; Magnesium Sulfate; Nervous System Diseases; Patient Safety; Pregnancy; Premature Birth; Tocolytic Agents | 2012 |
Implementation of a clinical practice guideline for antenatal magnesium sulphate for neuroprotection in Australia and New Zealand.
Topics: Australia; Cerebral Palsy; Female; Guideline Adherence; Health Care Surveys; Hospitals, Maternity; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Nervous System Diseases; Neuroprotective Agents; New Zealand; Practice Guidelines as Topic; Pregnancy; Prenatal Care; Tertiary Care Centers | 2013 |
Magnesium sulfate, cerebral palsy prevention, and medical protocols.
Topics: Cerebral Palsy; Female; Humans; Infant, Premature, Diseases; Magnesium Sulfate; Pregnancy; Prenatal Care | 2013 |
Magnesium sulfate and neonatal outcomes of preterm neonates.
Topics: Adult; Female; Fetal Membranes, Premature Rupture; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; New York; Obstetric Labor, Premature; Pregnancy; Pregnancy Outcome; Respiratory Distress Syndrome, Newborn; Retrospective Studies; Tocolytic Agents | 2002 |
Hope for perinatal prevention of cerebral palsy.
Topics: Asphyxia Neonatorum; Cerebral Palsy; Chorioamnionitis; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Neuroprotective Agents; Obstetric Labor, Premature; Pregnancy; Risk Factors | 2003 |
Magnesium sulfate for preterm neuroprotection.
Topics: Cerebral Palsy; Dose-Response Relationship, Drug; Female; Humans; Infant Mortality; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Neuroprotective Agents; Obstetric Labor, Premature; Pregnancy; Tocolytic Agents | 2004 |
Magnesium sulfate for preterm neuroprotection.
Topics: Cerebral Palsy; Female; Humans; Infant Mortality; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Neuroprotective Agents; Obstetric Labor, Premature; Pregnancy | 2004 |
The risks of extending the controversial use of tocolytic magnesium sulfate for the purpose of neuroprotection in preterm labor.
Topics: Cerebral Palsy; Female; Humans; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate; Neuroprotective Agents; Obstetric Labor, Premature; Pregnancy; Tocolytic Agents | 2004 |
The effects of the time interval from antenatal corticosteroid exposure to delivery on neonatal outcome of very low birth weight infants.
Topics: Adult; Anticonvulsants; Betamethasone; Bronchopulmonary Dysplasia; Cerebral Hemorrhage; Delivery, Obstetric; Enterocolitis, Necrotizing; Female; Glucocorticoids; Humans; Infant, Newborn; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Logistic Models; Magnesium Sulfate; Maternal Age; Retrospective Studies; Risk Factors; Time Factors | 2004 |
Antenatal magnesium treatment and neonatal illness severity as measured by the Score for Neonatal Acute Physiology (SNAP).
Topics: Cohort Studies; Databases as Topic; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Intensive Care Units, Neonatal; Magnesium Sulfate; Obstetric Labor, Premature; Pregnancy; Prenatal Exposure Delayed Effects; Retrospective Studies; Severity of Illness Index; Tocolytic Agents | 2005 |
Early neonatal hypotension in premature infants born to preeclamptic mothers.
Topics: Blood Pressure; Female; Fetus; Gestational Age; Humans; Hypotension; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Male; Pre-Eclampsia; Pregnancy; Risk Factors | 2006 |
Risk factors and clinical outcomes of pulmonary interstitial emphysema in extremely low birth weight infants.
Topics: Female; Fetus; Humans; Infant, Extremely Low Birth Weight; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate; Pregnancy; Pulmonary Emphysema; Risk Factors; Tocolytic Agents | 2006 |
Antenatal exposure to magnesium sulfate and the incidence of patent ductus arteriosus in extremely low birth weight infants.
Topics: Anticonvulsants; Dose-Response Relationship, Drug; Ductus Arteriosus, Patent; Female; Humans; Infant, Newborn; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Magnesium Sulfate; Male; Retrospective Studies; Tocolytic Agents | 2007 |
Antenatal magnesium sulphate neuroprotection in the preterm infant.
Topics: Animals; Cerebral Palsy; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Neuroprotective Agents; Randomized Controlled Trials as Topic; Treatment Outcome | 2007 |
Magnesium intoxication in a premature infant.
Topics: Adult; Female; Humans; Infant, Newborn; Infant, Premature, Diseases; Magnesium; Magnesium Sulfate; Maternal-Fetal Exchange; Pre-Eclampsia; Pregnancy; Respiratory Insufficiency | 1967 |
Ritodrine tocolysis and neonatal intraventricular-periventricular hemorrhage.
Topics: Cerebral Hemorrhage; Cerebral Ventricles; Female; Humans; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate; Nifedipine; Obstetric Labor, Premature; Pregnancy; Retrospective Studies; Ritodrine; Tocolysis | 1995 |
Cerebral palsy in very low birth weight infants, pre-eclampsia and magnesium sulphate.
Topics: Birth Weight; Cerebral Palsy; Female; Fetal Growth Retardation; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Magnesium Sulfate; Pre-Eclampsia; Pregnancy; Pregnancy Outcome; Risk Factors; Tocolysis | 1996 |
Pregnancy-induced hypertension and reduced intraventricular hemorrhage in preterm infants.
Topics: Adult; Birth Weight; Cerebral Hemorrhage; Cerebral Ventricles; Cesarean Section; Confidence Intervals; Female; Gestational Age; Humans; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate; Male; Pre-Eclampsia; Pregnancy; Retrospective Studies; Risk Factors; Tocolytic Agents | 1997 |
Maternal magnesium sulfate and the development of neonatal periventricular leucomalacia and intraventricular hemorrhage.
Topics: Anticonvulsants; Cerebral Hemorrhage; Female; Humans; Incidence; Infant, Newborn; Infant, Premature, Diseases; Leukomalacia, Periventricular; Magnesium Sulfate; Pregnancy; Pregnancy Complications; Retrospective Studies; Severity of Illness Index; Tocolytic Agents | 1999 |
Does exposure to magnesium sulfate in utero decrease the risk of necrotizing enterocolitis in premature infants?
Topics: Analysis of Variance; Anticonvulsants; Case-Control Studies; Dose-Response Relationship, Drug; Enterocolitis, Necrotizing; Female; Humans; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate; Obstetric Labor, Premature; Pre-Eclampsia; Pregnancy; Prenatal Exposure Delayed Effects; Regression Analysis; Risk Factors; Tocolytic Agents | 2001 |
The pediatric forum: neonatal hypermagnesemia: more causes and more symptoms.
Topics: Dose-Response Relationship, Drug; Humans; Infant, Newborn; Infant, Premature, Diseases; Magnesium; Magnesium Hydroxide; Magnesium Sulfate; Medication Errors | 2001 |
Maternal toxemia is associated with reduced incidence of germinal matrix hemorrhage in premature babies.
Topics: Cerebral Hemorrhage; Cerebral Palsy; Double-Blind Method; Female; Humans; Hypertension; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate; Phenobarbital; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Prospective Studies | 1992 |
Preterm labor: its diagnosis and management.
Topics: Adolescent; Adrenergic beta-Agonists; Adult; Female; Fluid Therapy; Humans; Indomethacin; Infant, Newborn; Infant, Premature, Diseases; Magnesium Sulfate; Obstetric Labor, Premature; Pregnancy; Risk; Time Factors; Ultrasonography | 1986 |
Magnesium therapy in premature neonates with apnea neonatorum.
Topics: Apnea; Birth Weight; Bradycardia; Drug Administration Schedule; Follow-Up Studies; Gestational Age; Humans; Infant, Newborn; Infant, Premature, Diseases; Magnesium Deficiency; Magnesium Sulfate; Maternal Age; Recurrence; Respiratory Distress Syndrome, Newborn; Retrospective Studies; Tachycardia | 1988 |
Microcolon of prematurity: a form of functional obstruction.
Topics: Colon; Female; Humans; Infant, Newborn; Infant, Premature, Diseases; Intestinal Obstruction; Magnesium Sulfate; Male; Pre-Eclampsia; Pregnancy; Radiography | 1986 |
Obstetric management of the very low birth weight fetus.
Topics: Adrenal Cortex Hormones; Extraction, Obstetrical; Female; Fetal Distress; Fetal Monitoring; Fetal Organ Maturity; Gestational Age; Humans; Indomethacin; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature, Diseases; Lung; Magnesium Sulfate; Obstetric Labor, Premature; Pregnancy; Respiratory Distress Syndrome, Newborn; Ritodrine; Terbutaline | 1986 |
The clinical and biochemical effects of excess magnesium in the newborn.
Topics: Birth Weight; Blood; Blood Proteins; Calcium; Female; Fetal Death; Gestational Age; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature, Diseases; Infusions, Parenteral; Injections, Intramuscular; Magnesium; Magnesium Sulfate; Male; Maternal-Fetal Exchange; Physical Examination; Pre-Eclampsia; Pregnancy; Respiratory Distress Syndrome, Newborn; Statistics as Topic; Time Factors; Umbilical Cord | 1971 |